Target intelligence / Profile preview

TBC1 domain family member 23 (TBC1D23)

Target
TBC1D23
Molecular classification
Adapter/scaffold protein, TBC (Tre2-Bub2-Cdc16) domain-containing protein, Rhodanese-like domain-containing protein, Pleckstrin homology (PH) domain-containing protein, Other: Golgi/endosomal trafficking protein (not a classical enzyme or receptor)
01

Overview

TBC1 domain family member 23 (TBC1D23) is a highly conserved, ubiquitously expressed protein that functions as an adapter essential for membrane trafficking, specifically mediating endosome-to-Golgi transport of certain cargo proteins by bridging endosomal vesicles with the Golgi apparatus[3][1][5]. Structurally, TBC1D23 features a catalytically inactive N-terminal TBC domain (not an active Rab GTPase-activating protein), a rhodanese-like domain (catalytically inactive in the sulfurtransferase/phosphatase sense), and a C-terminal pleckstrin homology (PH) domain[1][3][5]. The TBC and rhodanese domains interact with Golgi-localized proteins golgin-97 and golgin-245, while the PH domain binds components of the WASH complex on endosomes[3][5][7]. TBC1D23 is critical for neuronal development, and its mutations underlie pontocerebellar hypoplasia (PCH), a group of severe neurodevelopmental disorders[3][5]. Its main function is as a scaffold/adaptor in vesicular transport pathways, not as an enzyme or classical receptor, and it does not possess Rab-GAP or rhodanese catalytic activity[1][3][5]. There are currently no drugs known to target TBC1D23[4][5].

Other names
NS4ATP1FLJ11046HCV non-structural protein 4A-transactivated protein 1PCH11
02

Biological functions

Endosome-to-Golgi cargo traffickingMembrane trafficking (organelle-specific)Vesicle tethering to GolgiBridge between Golgi and endosomal vesiclesRecruitment of LKB1 for Golgi-specific signalingRegulation of neuronal development (especially in brain)
03

Disease associations

Neurodevelopmental disorders (specifically pontocerebellar hypoplasia, PCH)Other (essential for brain development; roles in rare genetic syndromes)
04

Safety considerations

Essential for brain development; loss-of-function mutations cause severe neurodevelopmental defectsTargeting may risk disruption of vesicular trafficking and neuronal growth
05

Biomarkers

Mutations in TBC1D23 as genetic biomarkers for pontocerebellar hypoplasia (PCH)

Beyond the preview

Go deeper on TBC1 domain family member 23 (TBC1D23).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on TBC1 domain family member 23 (TBC1D23).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call